Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor β subunits

Scott C. Harvey, Charles W Luetje

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

We constructed a series of chimeric and mutant neuronal nicotin c acetylcholine receptor β subunits to map amino acid residues that determine sensitivity to competitive antagonists. The β2 and β4 subunits form pharmacologically distinct receptors when expressed in combination with the α3 subunit in Xenopus oocytes. At equipotent acetylcholine concentrations, α3β2 is 56-fold more sensitive to blockade by dihydro-β-erythroidine than is α3β4. The α3β2 combination is also sensitive to long term blockade by neuronal bungarotoxin, whereas α3β4 is not. Pharmacological analysis of receptors formed by chimeric β subunits reveals that amino acid residues that determine both dihydro-β-erythroidine and neuronal bungarotoxin sensitivity are located within several sequence segments. The major determinant of sensitivity to both competitive antagonists is located between residues 54 and 63. A minor determinant of sensitivity to both antagonists lies between residues 1 and 54, whereas a minor determinant of NBT sensitivity lies between residues 74 and 80. Within region 54-63 of β2, mutant β2 subunits were used to identify threonine 59 as a residue critical in determining competitive antagonist sensitivity. Changing threonine 59 to lysine, as occurs in β4, causes a 9-fold decrease in dihydro-β-erythroidine sensitivity and a 71-fold decrease in neuronal bungarotoxin sensitivity. Changing polar threonine 59 to negatively charged aspartate causes a 2.5- fold increase in neuronal bungarotoxin sensitivity and has no effect on dihydro-β-erythroidine sensitivity.

Original languageEnglish
Pages (from-to)3798-3806
Number of pages9
JournalJournal of Neuroscience
Volume16
Issue number12
StatePublished - Jun 20 1996

Fingerprint

Nicotinic Receptors
Threonine
Amino Acids
Cholinergic Receptors
Xenopus
Aspartic Acid
Lysine
Acetylcholine
Oocytes
Pharmacology
neuronal bungarotoxin

Keywords

  • antagonists
  • chimera
  • dihydro-β-erythroidine
  • mutant
  • neuronal
  • neuronal bungarotoxin
  • nicotinic receptor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor β subunits. / Harvey, Scott C.; Luetje, Charles W.

In: Journal of Neuroscience, Vol. 16, No. 12, 20.06.1996, p. 3798-3806.

Research output: Contribution to journalArticle

Harvey, Scott C. ; Luetje, Charles W. / Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor β subunits. In: Journal of Neuroscience. 1996 ; Vol. 16, No. 12. pp. 3798-3806.
@article{f86bc253266c403fab6beb723ffd464a,
title = "Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor β subunits",
abstract = "We constructed a series of chimeric and mutant neuronal nicotin c acetylcholine receptor β subunits to map amino acid residues that determine sensitivity to competitive antagonists. The β2 and β4 subunits form pharmacologically distinct receptors when expressed in combination with the α3 subunit in Xenopus oocytes. At equipotent acetylcholine concentrations, α3β2 is 56-fold more sensitive to blockade by dihydro-β-erythroidine than is α3β4. The α3β2 combination is also sensitive to long term blockade by neuronal bungarotoxin, whereas α3β4 is not. Pharmacological analysis of receptors formed by chimeric β subunits reveals that amino acid residues that determine both dihydro-β-erythroidine and neuronal bungarotoxin sensitivity are located within several sequence segments. The major determinant of sensitivity to both competitive antagonists is located between residues 54 and 63. A minor determinant of sensitivity to both antagonists lies between residues 1 and 54, whereas a minor determinant of NBT sensitivity lies between residues 74 and 80. Within region 54-63 of β2, mutant β2 subunits were used to identify threonine 59 as a residue critical in determining competitive antagonist sensitivity. Changing threonine 59 to lysine, as occurs in β4, causes a 9-fold decrease in dihydro-β-erythroidine sensitivity and a 71-fold decrease in neuronal bungarotoxin sensitivity. Changing polar threonine 59 to negatively charged aspartate causes a 2.5- fold increase in neuronal bungarotoxin sensitivity and has no effect on dihydro-β-erythroidine sensitivity.",
keywords = "antagonists, chimera, dihydro-β-erythroidine, mutant, neuronal, neuronal bungarotoxin, nicotinic receptor",
author = "Harvey, {Scott C.} and Luetje, {Charles W}",
year = "1996",
month = "6",
day = "20",
language = "English",
volume = "16",
pages = "3798--3806",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "12",

}

TY - JOUR

T1 - Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor β subunits

AU - Harvey, Scott C.

AU - Luetje, Charles W

PY - 1996/6/20

Y1 - 1996/6/20

N2 - We constructed a series of chimeric and mutant neuronal nicotin c acetylcholine receptor β subunits to map amino acid residues that determine sensitivity to competitive antagonists. The β2 and β4 subunits form pharmacologically distinct receptors when expressed in combination with the α3 subunit in Xenopus oocytes. At equipotent acetylcholine concentrations, α3β2 is 56-fold more sensitive to blockade by dihydro-β-erythroidine than is α3β4. The α3β2 combination is also sensitive to long term blockade by neuronal bungarotoxin, whereas α3β4 is not. Pharmacological analysis of receptors formed by chimeric β subunits reveals that amino acid residues that determine both dihydro-β-erythroidine and neuronal bungarotoxin sensitivity are located within several sequence segments. The major determinant of sensitivity to both competitive antagonists is located between residues 54 and 63. A minor determinant of sensitivity to both antagonists lies between residues 1 and 54, whereas a minor determinant of NBT sensitivity lies between residues 74 and 80. Within region 54-63 of β2, mutant β2 subunits were used to identify threonine 59 as a residue critical in determining competitive antagonist sensitivity. Changing threonine 59 to lysine, as occurs in β4, causes a 9-fold decrease in dihydro-β-erythroidine sensitivity and a 71-fold decrease in neuronal bungarotoxin sensitivity. Changing polar threonine 59 to negatively charged aspartate causes a 2.5- fold increase in neuronal bungarotoxin sensitivity and has no effect on dihydro-β-erythroidine sensitivity.

AB - We constructed a series of chimeric and mutant neuronal nicotin c acetylcholine receptor β subunits to map amino acid residues that determine sensitivity to competitive antagonists. The β2 and β4 subunits form pharmacologically distinct receptors when expressed in combination with the α3 subunit in Xenopus oocytes. At equipotent acetylcholine concentrations, α3β2 is 56-fold more sensitive to blockade by dihydro-β-erythroidine than is α3β4. The α3β2 combination is also sensitive to long term blockade by neuronal bungarotoxin, whereas α3β4 is not. Pharmacological analysis of receptors formed by chimeric β subunits reveals that amino acid residues that determine both dihydro-β-erythroidine and neuronal bungarotoxin sensitivity are located within several sequence segments. The major determinant of sensitivity to both competitive antagonists is located between residues 54 and 63. A minor determinant of sensitivity to both antagonists lies between residues 1 and 54, whereas a minor determinant of NBT sensitivity lies between residues 74 and 80. Within region 54-63 of β2, mutant β2 subunits were used to identify threonine 59 as a residue critical in determining competitive antagonist sensitivity. Changing threonine 59 to lysine, as occurs in β4, causes a 9-fold decrease in dihydro-β-erythroidine sensitivity and a 71-fold decrease in neuronal bungarotoxin sensitivity. Changing polar threonine 59 to negatively charged aspartate causes a 2.5- fold increase in neuronal bungarotoxin sensitivity and has no effect on dihydro-β-erythroidine sensitivity.

KW - antagonists

KW - chimera

KW - dihydro-β-erythroidine

KW - mutant

KW - neuronal

KW - neuronal bungarotoxin

KW - nicotinic receptor

UR - http://www.scopus.com/inward/record.url?scp=0029889642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029889642&partnerID=8YFLogxK

M3 - Article

C2 - 8656274

AN - SCOPUS:0029889642

VL - 16

SP - 3798

EP - 3806

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 12

ER -